The Biden administration is moving towards loosening federal restrictions around marijuana, leading to a potential shift in policy. It is crucial for Americans to make their voices heard in this process, especially in light of the history of misinformation spread by the pot and tobacco industry. Despite the industry’s marketing, marijuana is highly addictive and dangerous, with scientific evidence linking its use to various mental health issues. It is not approved by the FDA for any medical condition, and many people who use it become addicted.
According to the 2022 National Survey on Drug Use and Health, nearly one-third of past-year marijuana users developed a cannabis use disorder, compared to other substances in Schedule I. Despite this, the Biden administration is pushing for its rescheduling using an arbitrary and unprecedented process. The administration has changed the criteria for determining whether marijuana has an accepted medical use, favoring a two-factor test that relies on state adoption of medical marijuana laws as evidence.
Rescheduling marijuana to Schedule III would benefit the pot industry and its allies in Big Tobacco, as it would allow for business expense deductions under IRS code Section 280E. This would lead to the production and promotion of stronger and more addictive drugs, serving the financial interests of pot profiteers and investors. It is essential for medical and legal professionals to rely on sound science and data in the decision-making process, rather than campaign politics or industry influence.
The Obama administration had previously concluded that marijuana belonged in Schedule I based on legal criteria, a decision that still holds true today as the science behind the harms of marijuana use has become clearer. THC products have become stronger and more potent, leading to serious harm among young people and minorities. The ultimate goal of pro-pot activists is full legalization and normalization, and rescheduling to Schedule III would be a step towards achieving that goal.
Americans need to be actively involved in the process of determining the status of marijuana to ensure that scientific evidence and public health concerns are prioritized over political and industry interests. As marijuana use continues to rise, it is important to recognize that rescheduling is not about medicine but about politics and financial gain for the industry. By understanding the real harms associated with an expanded marijuana industry, individuals can advocate for policies that prioritize public health and safety over profit.
